Evidence map›Paper›PMID 32794016›Full record

ArticleJournal of the Egyptian National Cancer Institute2020

Localized Wilms' tumor in low-middle-income countries (LMIC): how can we get better?

Hosam Y Asfour, Sahar A Khalil, Al-Shimaa Zakaria, El-Sayed Ashraf, Wael Zekri

Abstract read
In one paragraph

Article in Journal of the Egyptian National Cancer Institute, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hosam Y AsfourPediatric oncology department, National Cancer Institute, Cairo University, and 57357 CCHE Hospital, Fom El-khalig Square, Kasr El-Aini St, Cairo, 11796, Egypt. hosam.asfour@gmail.com.
Sahar A KhalilPediatric oncology department, National Cancer Institute, Cairo University, and 57357 CCHE Hospital, Fom El-khalig Square, Kasr El-Aini St, Cairo, 11796, Egypt.
Al-Shimaa ZakariaPathology Department, National Cancer Institute, Cairo University and 57357 CCHE Hospital, Cairo, Egypt.
El-Sayed AshrafSurgical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Wael ZekriPediatric oncology department, National Cancer Institute, Cairo University, and 57357 CCHE Hospital, Fom El-khalig Square, Kasr El-Aini St, Cairo, 11796, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWilms' tumor (WT) represents about 6% of all childhood cancers. The overall survival markedly improved to exceed 90% in developed countries, yet some studies from developing counties still have poorer outcomes. The aim of this study is to assess the clinical outcome and the different prognostic factors that influence the outcome of pediatric loco-regional WT cases treated at National Cancer Institute (NCI), Cairo University, Egypt. This is a retrospective study which included pediatric loco-regional WT patients presented between January 2008 and December 2017. Patients were followed up till June 2019.

resultsNinety-two eligible patients were included. Median age was 3 years (range 1 month-9 years). Abdominal mass was the commonest presentation (72.8%). The 5-year EFS and OS of the whole group was 83.7% and 94.6% retrospectively. Despite having a similar EFS (84.8 vs. 82.6%), stage III patients had a significantly lower OS than those in stages I and II (89.1% vs. 100%, p value 0.024). Twelve patients had unfavorable histology and had a significantly lower EFS and OS than the patients with favorable histology (50 and 83.3% vs. 88.8 and 96.3%, p value < 0.001 and 0.043, respectively).

conclusionLoco-regional Wilms' tumor cases treated in Egypt had OS nearly the same as in developed countries, but had a lower EFS than expected mainly stages I and II. The stage and histological type are the main factors influencing the survival, and further studies are needed to investigate nuclear unrest grades and proper management of such cases.

Indexed as

Developing CountriesKidney NeoplasmsWilms TumorChildEgyptHumansInfantNeoplasm StagingRetrospective StudiesEgyptLoco-regionalOutcomePediatricWilms’ tumor

Identifiers

PMID32794016
PMCPMC13317114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.